Differences in Receipt of Multimodality Therapy by Race, Insurance Status, and Socioeconomic Disadvantage in Patients with Resected Pancreatic Cancer
Author
Hao, Scarlett; Mitsakos, Anastasios; Irish, William; Tuttle‐Newhall, Janet Elizabeth; Parikh, Alexander A.; Snyder, Rebecca A.
Date
2022
Citation:
APA:
Hao, Scarlett, & Mitsakos, Anastasios, & Irish, William, & Tuttle‐Newhall, Janet Elizabeth, & Parikh, Alexander A., & Snyder, Rebecca A.. (January 2022).
Differences in Receipt of Multimodality Therapy by Race, Insurance Status, and Socioeconomic Disadvantage in Patients with Resected Pancreatic Cancer.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/12335
MLA:
Hao, Scarlett, and Mitsakos, Anastasios, and Irish, William, and Tuttle‐Newhall, Janet Elizabeth, and Parikh, Alexander A., and Snyder, Rebecca A..
"Differences in Receipt of Multimodality Therapy by Race, Insurance Status, and Socioeconomic Disadvantage in Patients with Resected Pancreatic Cancer". .
. (),
January 2022.
April 25, 2024.
http://hdl.handle.net/10342/12335.
Chicago:
Hao, Scarlett and Mitsakos, Anastasios and Irish, William and Tuttle‐Newhall, Janet Elizabeth and Parikh, Alexander A. and Snyder, Rebecca A.,
"Differences in Receipt of Multimodality Therapy by Race, Insurance Status, and Socioeconomic Disadvantage in Patients with Resected Pancreatic Cancer," , no.
(January 2022),
http://hdl.handle.net/10342/12335 (accessed
April 25, 2024).
AMA:
Hao, Scarlett, Mitsakos, Anastasios, Irish, William, Tuttle‐Newhall, Janet Elizabeth, Parikh, Alexander A., Snyder, Rebecca A..
Differences in Receipt of Multimodality Therapy by Race, Insurance Status, and Socioeconomic Disadvantage in Patients with Resected Pancreatic Cancer. .
January 2022;
():
.
http://hdl.handle.net/10342/12335. Accessed
April 25, 2024.
Collections